EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Ovarian Cancer Biomarkers Mapping To Improve Outcomes 1st Ed 2021

Name: Ovarian Cancer Biomarkers Mapping To Improve Outcomes 1st Ed 2021
SKU: BELL-35084144
Price: 31.00 USD
Availability: InStock
Rating: 4 (76 reviews)

SKU: BELL-35084144

$ 31.00 ~~$ 45.00~~ (-31%)

4.0

76 reviews

Ovarian Cancer Biomarkers Mapping To Improve Outcomes 1st Ed 2021 instant download after payment.

Publisher: Springer

File Extension: PDF

File size: 4.19 MB

Pages: 236

Author: ,

ISBN: 9789811618727, 9811618720

Language: English

Year: 2021

Edition: 1st ed. 2021

Product desciption

Ovarian Cancer Biomarkers Mapping To Improve Outcomes 1st Ed 2021 by , 9789811618727, 9811618720 instant download after payment.

This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in the advancement of precision medicine. The initial chapter discusses our current understanding of the origin, development, progression and tumorigenesis of ovarian cancer. In turn, the book highlights the development of resistance, disease occurrence, and poor prognosis that are the hallmarks of ovarian cancer. The book then reviews the role of deep molecular and cellular profiling to overcome challenges that are associated with the treatment of ovarian cancer. It explores the use of genome-wide association analysis to identify genetic variants for the evaluation of ovarian carcinoma risk and prognostic prediction. Lastly, it highlights various diagnostic and prognostic ovarian cancer biomarkers for the development of molecular-targeted therapy.